JPMORGAN MID CAP VALUE FUND CLASS R3 (JMVPX US) stock market data APIs
35.3827
0(0%)
as of July 18, 2025
Try our APIs with
free plan!
JPMORGAN MID CAP VALUE FUND CLASS R3 Financial Data Overview
Price chart is built with
Anychart
Prev. Close
35.3827
Open
35.3827
High
35.3827
Low
35.3827
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get JPMORGAN MID CAP VALUE FUND CLASS R3 data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get JPMORGAN MID CAP VALUE FUND CLASS R3 End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
JPMORGAN MID CAP VALUE FUND CLASS R3 News
New
Notice convening the NKT Annual General Meeting
Company Announcement 3 March 2021 Announcement No. 3 Notice convening the NKT Annual General Meeting The Annual General Meeting of NKT A/S will be held Thursday 25 March 2021 at 3.00 p.m. (CE...
Notice convening the NKT Annual General Meeting
Company Announcement 3 March 2021 Announcement No. 3 Notice convening the NKT Annual General Meeting The Annual General Meeting of NKT A/S will be held Thursday 25 March 2021 at 3.00 p.m. (CE...
argenx Announces FDA Acceptance of BLA Filing for Efgartigimod for the Treatment of Generalized Myasthenia Gravis
Regulated Information/Inside Information argenx Announces FDA Acceptance of BLA Filing for Efgartigimod for the Treatment of Generalized Myasthenia Gravis If approved, efgartigimod will be the first...
argenx Announces FDA Acceptance of BLA Filing for Efgartigimod for the Treatment of Generalized Myasthenia Gravis
Regulated Information/Inside Information argenx Announces FDA Acceptance of BLA Filing for Efgartigimod for the Treatment of Generalized Myasthenia Gravis If approved, efgartigimod will be the first...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
